ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
| BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
| First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
| Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
| EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
| Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
| NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
| Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
| Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
| KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |